MedEngine Oy announced today that Saku Torvinen, PhD, joins MedEngine Oy as Director of Market Access. At MedEngine, he will be responsible for the launch…
Tero Ylisaukko-oja11/03/2021
Finnish Haemophilia patients have comprehensive followup and most receive factor replacement therapy, shows the results from the HemoHEOR study which was published this week in…
Aino Vesikansa23/11/2020
Obesity has a significant negative impact on quality of life (QoL) and perceived physical and psychological working ability. This summarizes the first results of the…
Aino Vesikansa06/11/2020
Welcome to watch the second episode of Insight Talks! In this episode, we get to discuss with Sirpa Soini, the Director of THL Biobank. Inside…
Miika Fadjukov16/04/2020
Welcome to Insight Talks! In this first episode of Insight Talks, we get to host a guest who has seen an amazingly full view of…
Miika Fadjukov28/02/2020
Haemophilia treatment in Finnish university hospitals is of excellent quality and at costs reasonable within European standards, shows the HemoHEOR study conducted by MedEngine that…
MedEngine15/01/2020
